Gen1e unveils new era in p38 alpha kinase inhibition for inflammatory diseases
FierceBiotech - 31-Jul-2019A breath of fresh air for patents with acute respiratory distress syndrome
Previously the Live Forever Club – now more focused on campaigning for radical life extension in the UK
Writer and editor at Fierce Biotech
Amirah Al Idrus is a copy editor for the FierceMarkets Life Sciences group and a contributing writer for FierceVaccines. Before joining the Fierce Life Sciences team, Amirah completed a master's degree in journalism at the University of Maryland, where she concentrated in multimedia journalism. While at Maryland, she worked for the university's Capital News Service as a web developer, and interned at the Washington Business Journal. She has covered issues ranging from Maryland politics and policy to prison finance.
Visit website: https://www.fiercebiotech.com/person/amirah-al
See also
Web resource providing the latest biotech news, articles, and resources related to biotech company news
Details last updated 26-Nov-2024
A breath of fresh air for patents with acute respiratory distress syndrome